NOVAVAX INC Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Novavax Inc quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • Novavax Inc Return On Equity for the quarter ending June 30, 2024 was 43.7 %, a 46.9% decline year-over-year.
  • Novavax Inc annual Return On Equity for 2023 was 71.6 %, a 57.8% decline from 2022.
  • Novavax Inc annual Return On Equity for 2022 was 170 %.
  • Novavax Inc annual Return On Equity for 2021 was -368 %, a 96.8% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 43.7 -38.7 -46.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 52.9 -131 -71.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 71.6 -98 -57.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 74.1 -342 -82.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 82.4 -2.36K -96.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 184 +756 Jan 1, 2023 Mar 31, 2023
Q4 2022 170 +538 Oct 1, 2022 Dec 31, 2022
Q3 2022 417 +566 Jul 1, 2022 Sep 30, 2022
Q2 2022 2.44K +2.59K Apr 1, 2022 Jun 30, 2022
Q1 2022 -573 -447 -355% Jan 1, 2022 Mar 31, 2022
Q4 2021 -368 -181 -96.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -150 +1.2K +88.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -151 -324 -187% Apr 1, 2021 Jun 30, 2021
Q1 2021 -126 -205 -259% Jan 1, 2021 Mar 31, 2021
Q4 2020 -187 -262 -351% Oct 1, 2020 Dec 31, 2020
Q3 2020 -1.35K -1.43K -1655% Jul 1, 2020 Sep 30, 2020
Q2 2020 173 +61.2 +54.6% Apr 1, 2020 Jun 30, 2020
Q1 2020 78.8 -57.5 -42.2% Jan 1, 2020 Mar 31, 2020
Q4 2019 74.6 -78.9 -51.4% Oct 1, 2019 Dec 31, 2019
Q3 2019 86.6 -92.7 -51.7% Jul 1, 2019 Sep 30, 2019
Q2 2019 112 -93.2 -45.4% Apr 1, 2019 Jun 30, 2019
Q1 2019 136 -86.5 -38.8% Jan 1, 2019 Mar 31, 2019
Q4 2018 153 -125 -44.9% Oct 1, 2018 Dec 31, 2018
Q3 2018 179 -274 -60.4% Jul 1, 2018 Sep 30, 2018
Q2 2018 205 -1.72K -89.4% Apr 1, 2018 Jun 30, 2018
Q1 2018 223 +1.01K Jan 1, 2018 Mar 31, 2018
Q4 2017 278 +608 Oct 1, 2017 Dec 31, 2017
Q3 2017 453 +642 Jul 1, 2017 Sep 30, 2017
Q2 2017 1.93K +2.04K Apr 1, 2017 Jun 30, 2017
Q1 2017 -787 -719 -1057% Jan 1, 2017 Mar 31, 2017
Q4 2016 -330 -286 -660% Oct 1, 2016 Dec 31, 2016
Q3 2016 -189 -157 -497% Jul 1, 2016 Sep 30, 2016
Q2 2016 -112 -82.3 -273% Apr 1, 2016 Jun 30, 2016
Q1 2016 -68.1 -36.2 -113% Jan 1, 2016 Mar 31, 2016
Q4 2015 -43.4 -8.97 -26.1% Oct 1, 2015 Dec 31, 2015
Q3 2015 -31.7 -3.78 -13.5% Jul 1, 2015 Sep 30, 2015
Q2 2015 -30.1 -2.77 -10.1% Apr 1, 2015 Jun 30, 2015
Q1 2015 -31.9 +0.92 +2.8% Jan 1, 2015 Mar 31, 2015
Q4 2014 -34.4 +2.28 +6.21% Oct 1, 2014 Dec 31, 2014
Q3 2014 -27.9 +13.5 +32.6% Jul 1, 2014 Sep 30, 2014
Q2 2014 -27.4 +25.2 +47.9% Apr 1, 2014 Jun 30, 2014
Q1 2014 -32.8 +11.7 +26.2% Jan 1, 2014 Mar 31, 2014
Q4 2013 -36.7 +7.67 +17.3% Oct 1, 2013 Dec 31, 2013
Q3 2013 -41.4 +0.49 +1.17% Jul 1, 2013 Sep 30, 2013
Q2 2013 -52.5 -16.5 -45.7% Apr 1, 2013 Jun 30, 2013
Q1 2013 -44.5 -9.33 -26.5% Jan 1, 2013 Mar 31, 2013
Q4 2012 -44.4 Oct 1, 2012 Dec 31, 2012
Q3 2012 -41.9 Jul 1, 2012 Sep 30, 2012
Q2 2012 -36.1 Apr 1, 2012 Jun 30, 2012
Q1 2012 -35.2 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.